Human pathology
Cure8 research brief
Why This Matters
If confirmed, a pathology marker visible on routine biopsy (EGC patterns by SOX10 IHC) could help predict which children with ulcerative colitis are more likely to have improved mucosal inflammation over the first year, potentially informing early treatment choices.
Who Should Pay Attention
Pediatric IBD clinicians, pathologists, researchers studying IBD biomarkers or the enteric nervous system, and parents/caregivers of children newly diagnosed with ulcerative colitis.
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
This study reviewed colon mucosal samples from children with UC and classified enteric glial cell patterns using SOX10 staining. About half of pediatric UC patients had non-basal glial aggregates (NBGAs) in the mucosa.
Those with NBGAs were more likely to show improved histologic scores (Geboes and Nancy indices) and reduced fecal calprotectin at roughly one-year follow-up compared with those without NBGAs.
The authors propose a routine approach to documenting EGCs in GI mucosal pathology and suggest these profiles could inform early therapeutic decisions, but this report describes an observational association rather than proof that EGCs cause better outcomes.
Keep In Mind
This is an observational, pathology-based study reported in the article abstract; it shows associations in a pediatric cohort and does not prove causation. Results should be considered preliminary until validated in independent and prospective studies.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationHuman pathology
AuthorsHarry J Rosenberg, Dongfang Yang, Riti S Bhalla +4 more
InstitutionRhode Island Hospital Department of Pathology, 593 Eddy Street, APC12-126, Providence, RI, USA 02903. Electronic address: hrosenberg@brownhealth.org.
Study typeJournal article
Indexed viaPubMed
Source typeResearch paper
PublishedSep 14, 2026, 12:00 AM
Content availableJournal abstract
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Vancomycin Efficacy in Response to Dysbiosis in Atypical Colitis
This trial tests whether oral vancomycin can help children with atypical ulcerative colitis or PSC-associated colitis and whether changes in gut bacteria or metabolites explain response. If effective and safe, it could...
ND-12 Combined With H-6 for Adult Chronic Inflammatory Diarrhea
Early-phase trials test whether new treatments are safe and show biological activity. This study measures fecal calprotectin, a biomarker of intestinal inflammation, so it could provide early signals about whether ND-12...
Machine Learning-Based Prediction of Treatment Response to Vitamin D3 in Adolescents and Young Adults with Inflammatory Bowel Disease: A Prospective, Open-Label, Alternation-Based Comparative Study
Vitamin D supplementation is commonly considered in people with IBD because deficiency is frequent and low vitamin D may relate to inflammation.